J. Leibovici et al., CELL-MEMBRANE FLUIDITY AND ADRIAMYCIN RETENTION IN A TUMOR PROGRESSION MODEL OF AKR LYMPHOMA, Biochimica et biophysica acta. Biomembranes, 1281(2), 1996, pp. 182-188
Counteraction of drug resistance is a major challenge in cancer therap
y, particularly in advanced stages. The main mechanism of multidrug re
sistance is related to an increased drug efflux. In the present study
we examined the effect of modifying cell membrane lipid fluidity on up
take of adriamycin (ADR) in cells of AKR lymphoma malignancy variants.
Modification of cell membrane fluidity, either by lecithin or by leci
thin-cholesterol mixtures, induced in a high proportion of cells of al
l variants a higher capacity to accumulate ADR. The chemosensitizing e
ffect, for lecithin in particular, was proportional to the degree of m
alignancy of the lymphoma variants. The increased ADR uptake was up to
1.4-fold in the variant of lowest malignancy and up to 5-fold in the
one of highest aggressiveness. This tendency correlates with our previ
ous studies and is of particular value since highly-malignant tumors a
re often drug resistant. The cholesterol-lecithin mixture, induced, ho
wever, in part of the variants the appearance of a small subpopulation
with very low ADR permeability. Cell membrane rigidification is of va
lue for exposing tumor cell cryptic antigens but may be deleterious wh
en used in conjunction with chemotherapy.